CombiChemLab - News - January 2003

Untitled Document

NEWS: JANUARY 2003

-1/31/2003-

The Strategic Research Institute (SRI) will host the "Growth Factor Receptors in Drug Discovery & Development" conference on May 5-6, 2003, in Philadelphia, PA. To read article click here. SRI promotes and hosts a broad range of scientific oriented conferences. For more information on SRI here at CombiChem Lab click here.

LION bioscience AG launches new comprehensive integration platform for faster drug discovery: LION DiscoveryCenter. To read article click here. LION offers its iDiscovery™ technologies and services for drug discovery. For a review of Lion's services here at CombiChem Lab click here.

Rigel Pharmaceuticals cuts another 24 positions from its workforce. To read article click here.

Whistleblower lawsuit hits Merck & Co. for allegedly overcharging the government for its drug Pepcid for heartburn and ulcer treatment. To read article click here.

FDA approves Biogen Inc.'s drug Amevive® (alefacept) for psoriasis. To read article click here and here.

The Securities and Exchange Commission charges a manager at Sepracor Inc. with insider trading. To read article click here.

Simulations Plus Inc. releases GastroPlus™ version 3.3 for drug absorption and pharmacokinetics simulations. To read article click here.

GPC Biotech AG and Eli Lilly and Company form drug discovery technology collaboration. To read article click here.

GPC Biotech AG introduces new drug-protein interaction technology: LeadCode™. To read article click here.

deCODE genetics and Vertex Pharmaceuticals sign pharmacogenomics alliance. To read article click here.

-1/30/2003-

Press Release: MDL® and SciTegic® form strategic alliance. To read press release click here. MDL provides software and databases for combinatorial chemistry, drug discovery and HTS. For a review of MDL's software for combinatorial chemistry here at CombiChem Lab click here.

Bristol-Myers Squibb cuts another 113 jobs. To read article click here.

King Pharmaceuticals Inc. to buy the rights for two drugs of Elan Corp.'s for $850 million. To read article click here.

IVAX Corporation and the Laboratory of Molecular Biology of the National Cancer Institute form research collaboration to develop a recombinant immunotoxin to selectively kill HIV-infected cells. To read article click here.

Sunesis Pharmaceuticals Inc. receives Small Business Innovative Research (SBIR) grant for anti-cander research focusing on undisclosed kinase target. To read article click here.

Iconix Pharmaceuticals Inc. and Schering-Plough Research Institute form toxicogenomics research collaboration. To read article click here.

-1/29/2003-

Thales Nanotechnology, a ComGenex Inc. subsidiary, has been awarded a Small Business Incentive grant. To read article click here. Comgenex Inc. provides services for the synthesis of drug-like compounds for high-throughput screening (HTS) and drug discovery. For a review of Comgenex Inc's services here at CombiChem Lab click here.

The Strategic Research Institute (SRI) will host the "siRNA in Drug Discovery & Development" conference on March 24-25, 2003, in La Jolla, CA. To read article click here. SRI promotes and hosts a broad range of scientific oriented conferences. For more information on SRI here at CombiChem Lab click here.

The Strategic Research Institute (SRI) will host the 8th "Antibacterial Drug Discovery & Development Summit" conference on March 24-25, 2003, in Princeton, NJ. To read article click here. SRI promotes and hosts a broad range of scientific oriented conferences. For more information on SRI here at CombiChem Lab click here.

Dyax Corp. initiates phase II clinical trial of its DX-88 compound for the treatment of hereditary angioedema (HAE). To read article click here. Biotage Inc., a division of Dyax Corp., has a broad variety of purification systems for drug discovery. To find a review of Biotage's purification systems here at CombiChem Lab click here.

Corixa Corp. and GlaxoSmithKline Biologicals partner to develop vaccines agains multiple solid cancer tumors. To read article click here.

PerkinElmer Life and Analytical Sciences introduce the new compact AAnalyst™ 400. To read article click here.

Amylin Pharmaceuticals Inc. acquires rights and several patents for glucagon-like peptide 1 (GLP-1) for the treatment of congestive heart failure (CHF). To read article click here.

Symyx Technologies Inc. and Celanese Chemicals extend catalysts research collaboration. To read article click here.

ChemCodes Inc. signs compound synthesis agreement with Wyeth. To read article click here.

Lorus Therapeutics Inc. receives U.S. patent entitled "oligonucleotide sequences complementary to thioredoxin and thioredoxin reductase genes and methods of same to modulate cell growth." To read article click here.

-1/28/2003-

Bionomics develops animal model NeoVascMouse™ for angiogenesis research. To read article click here.

Molecular Devices Corporation launches its new FLIPR® Calcium 3 Assay Kit. To read article click here.

-1/27/2003-

Press Release: Advanced ChemTech, a leading developer of instrumentation and chemicals technology for peptide, organic and combinatorial chemistry, has updated its web site that may be found at www.advancedchemtech.com. To read press release click here. Advanced ChemTech (ACT) provides automated and semi-automated systems and resins for combinatorial chemistry, polymer-assisted, and high-throughput organic and peptide synthesis. For a review of ACT's systems here at CombiChem Lab click here and here.

Press Release: For high throughput laboratories currently focusing on microplate assays, the versatile UltraVap from Porvair Sciences is the sample concentrator of choice. To read press release click here.

Discovery Partners International Inc. (DPII) launches its new Crystal Farm™ Imaging System for protein crystallization. To read article click here. DPII offers its IRORI microreactor-based product line for high-throughput solid phase combinatorial chemistry. For a review of IRORI's product line here at CombiChem Lab click here.

Fisher Scientific International Inc. acquires Mimotopes Pty. Limited. To read article click here. Mimotopes offers its SynPhase™ line of grafted products for solid phase combinatorial chemistry. For a review of Mimotopes' SynPhase™ grafted products here at CombiChem Lab click here.

Ciphergen Biosystems Inc. and Pfizer Inc. expand protein biomarker discovery collaboration. To read article click here.

Onyx Pharmaceuticals Inc. stops development of its experimental cancer-killing virus ONYX-15 to focus on anti-cancer compound BAY 43-9006 which is developing in collaboration with Bayer AG. Onyx is also cutting its work force by 25%. To read article click here.

FDAnews announces its newest publication: Pharmaceutical Corporate Compliance Report. To read article click here.

Drug & Market Development Publications (D&MD) releases new report: "Managing Toxicology for the Future: Improving Predictive Power Through Integrated Technologies." To read article click here.

Tularik Inc. initiates Phase I clinical trials for T131 for treatment of type 2 diabetes. To read article click here.

MorphoSys AG and Lonza Biologics sign 5-year antibody manufacturing agreement. To read article click here.

Beckman Coulter Inc. introduces its new ProteomeLab PF 2D system and its ProteomeLab PA-800 Protein Characterization System for protein discovery. To read article click here.

-1/24/2003-

Press Release: Available from INTEGRA Biosciences the TECNOMAT line is a unique modular system that sets new standards in Petri dish media processing. To read press release click here.

Pharmacia Corp. to allow companies to manufacture generic drugs of its AIDS drug Rescriptor (delavirdine) to be sold in poor countries. To read press release click here.

FDA approves Teva Pharmaceutical Industries Ltd.'s generic form Akzo Nobel's depression drug Remeron. To read press release click here.

-1/23/2003-

GlaxoSmithKline stops clinical trials for its asthma inhaler drug Serevent. To read article click here.

Gilead Sciences Inc. acquires Triangle Pharmaceuticals Inc. To read article click here.

Drug & Market Development Publications (D&MD) releases new report: "The Bioprocessing Industry: Increasing Capacity, Production, and Efficiency." To read article click here.

GeneData and Novartis Pharma sign multi-year collaboration agreement to develop software platform to visualize and analyze high-throughput screening (HTS) and compound profiling data. To read article click here.

Cambridge Antibody Technology Group PLC and Oxford Glycosciences PLC to merge. To read article click here.

Novartis AG increases stake in Roche AG. Roche not interested in merging. To read article click here.

Human Genome Sciences Inc. forms Human Genome Sciences Europe GmbH. To read article click here.

Novartis stops development of Dr. Reddy's Laboratories's compound DRF 4158 (LBL-752) to pursue instead a dual acting insulin sensitizer compound. To read article click here.

Decode Genetics Inc. and IBM to form three-year collaboration to market Decode's gene software. To read article click here.

-1/22/2003-

Press Release: ASINEX Ltd. and Vasopharm BIOTECH, are pleased to announce the completion of the first part of a multi-stage lead generation project for novel Nitric Oxide synthase inhibitors. To read press release click here. ASINEX offers a large collection of highly pure and diverse small organic compounds for CombiChem and HTS as well as its services for chemistry and drug discovery. For a review of ASINEX's compound collections and services here at CombiChem Lab click here.

The Center for Business Intelligence (CBI) announces its 2003 Pharmaceutical Conference Events. To read article click here. CBI organizes and hosts a series of conferences in the pharmaceutical areas. For more information on CBI here at CombiChem Lab click here.

IBC to host the "Proteomics and Protein Microarrays " conferences on April 7-9, 2003, in San Diego, CA. For more information on this conference click here. IBC promotes and hosts a broad range of scientific oriented conferences. For more information on IBC here at CombiChem Lab click here.

LION bioscience AG signs a two-year global SRS licensing agreement with Johnson & Johnson Pharmaceutical Research & Development. To read article click here. LION offers its iDiscovery™ technologies and services for drug discovery. For a review of Lion's services here at CombiChem Lab click here.

Lynx Therapeutics Inc. to cut staff by 25%. To read article click here.

Isis Pharmaceuticals Inc.'s GeneTrove unit forms target validation aliance with Pfizer Inc. To read article click here.

-1/21/2003-

IBC to host the "Protein Discovery & Engineering" conference on March 24-27, 2003, in San Francisco, CA. For more information on this conference click here. IBC promotes and hosts a broad range of scientific oriented conferences. For more information on IBC here at CombiChem Lab click here.

The Strategic Research Institute (SRI) will host the "G-Protein Coupled Receptors in Drug Discovery & Development" conference on March 17-18, 2003, in Philadelphia, PA. To read article click here. SRI promotes and hosts a broad range of scientific oriented conferences. For more information on SRI here at CombiChem Lab click here.

Argonaut Technologies Inc. introduces the Advantage Series™ 3400 workstationg for automated process chemistry R&D. To read article click here. Argonaut Technologies provides chemical and reagents as well as semiautomated synthesizers for parallel synthesis. For a review of Argonaut Technologies' chemicals and semiautomated synthesizers here at CombiChem Lab click here and here, respectively.

Geron Corp. to cut staff 40 percent to continue development of anti-cancer drug GRN163. To read article click here.

Schering-Plough Corp.'s asthma drug Asmanex receives European Union approval. To read article click here.

U.K. high court revokes 2 Teva Pharmaceutical Industries Ltd.'s patents. To read article click here.

AngioDesign Inc.'s founders determine crystal structure of angiotensin-converting enzyme (ACE), the results are published on January 19, 2003, in the journal Nature. To read article click here.

Locus Pharmaceuticals Inc. and DuPont Crop Protection for research collaboration. To read article click here.

Deltagen Inc. launches new user-friendly website tools for DeltaOne™ customers. To read article click here.

Deltagen Inc.'s COO resigns. To read article click here.

Serono and GeneProt Inc. form research collaboration. To read article click here.

High Throughput Genomics Inc. introduces the Pentadot Plus™ for the quantification of RNA expression levels in cells. To read article click here.

-1/20/2003-

Accelrys Inc. releases Cerius2™ version 4.8 with new modules such as C2.LibX for combinatorial library design, C2.NNet for back propagation neural networks, and C2.AutoLudi for de novo design. To read article click here. Accelrys Inc. provides software packages for molecular modeling, drug discovery, life science, material science, combinatorial chemistry and high-throughput screening. For a review of Accelrys' software packages here at CombiChem Lab click here.

FDA approves GlaxoSmithKline's Lamictal tablets for epilepsy in children. To read article click here.

Medarex Inc. and Abbott Laboratories form research colaboration to develop fully human therapeutic antibodies for oncology, neuroscience and infectious diseases. To read article click here.

-1/17/2003-

The Strategic Research Institute (SRI) will host the "Antibody World Summit" conference on February 24-28, 2003, in San Diego, CA. To read article click here. SRI promotes and hosts a broad range of scientific oriented conferences. For more information on SRI here at CombiChem Lab click here.

Eli Lilly and Company signs agreement with LION bioscience AG to incorporate LION's SRS platform in Lilly's drug discovery research. To read article click here. LION offers its iDiscovery™ technologies and services for drug discovery. For a review of Lion's services here at CombiChem Lab click here.

Pharma Marketing Ltd. files lawsuit against Elan Corporation. To read article click here.

Amgen Inc.'s Phase III clinical study of ENBREL® (etanercept) gives positive results for psoriasis treament. To read article click here.

-1/16/2003-

Press Release: Advanced ChemTech Europe has announced its presence at the German Peptide Symposium in Berlin, Germany (23-26th March 2003) with its latest range of products to support productive peptide chemistry. To read press release click here. Advanced ChemTech (ACT) provides automated and semi-automated systems and resins for combinatorial chemistry, polymer-assisted, and high-throughput organic and peptide synthesis. For a review of ACT's systems here at CombiChem Lab click here and here.

Johnson & Johnson to acquire 3-Dimensional Pharmaceuticals Inc. for $88 million. To read article click here. 3DP provides services in combinatorial chemistry and drug discovery. For a review of 3DP's services here at CombiChem Lab click here.

GlaxoSmithKline acquires exclusive rights to produce and market Ono Pharmaceutical Co.'s HIV inhibitor ONO-4128. To read article click here.

Pfizer Inc. looses patent litigation against Apotex Corp. over the drug Neurontin for epilepsy. To read article click here.

atugen AG and Isis Pharmaceuticals Inc. form genomics research collaboration. To read article click here.

Genomics Collaborative Inc. and Celera Diagnostics form research collaboation for rheumatoid arthritis. To read article click here.

Evotec OAI AG reaches milestone in drug discovery chemistry collaboration with Vertex Pharmaceuticals. To read article click here.

-1/15/2003-

MDS Sciex introduces first product of its new line of proteomics separation product line: ProteoSpin™. To read article click here. Applied Biosystems/MDS Sciex provides mass spectrometer systems for combinatorial chemistry and drug discovery. For a review of Applied Biosystems/MDS Sciex's systems here at CombiChem Lab click here.

Locus Discovery Inc. changes its name to Locus Pharmaceuticals Inc. To read article click here.

Abbott Laboratories to use Compugen Ltd.'s technology to analize human genomic data. To read article click here.

Boehringer Ingelheim Pharmaceuticals Inc. and Structural GenomiX Inc. form drug discovery collaboration. To read article click here.

-1/14/2003-

Iconix Pharmaceuticals Inc. and MDL Information Systems Inc. sign agreement to link DrugMatrix™ with MDL® ISIS Enterprise Edition. To read article click here. MDL provides software and databases for combinatorial chemistry, drug discovery and HTS. For a review of MDL's software for combinatorial chemistry here at CombiChem Lab click here.

FDA approves Abbott Laboratories Inc.'s drug Humira for rheumatoid arthritis. Abbott to freeze salaries for the next six months to launch Humira. To read article click here.

FDA turns downs Transkaryotic Therapies Inc.'s drug Replagal for Fabry's disease. To read article click here.

Schering-Plough Corp. receives European Union approval for its drug Caelyx for treatment of breast cancer. To read article click here.

Eli Lilly and Company launches nationwide its new drug Strattera™ (atomoxetine HCl) for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). To read article click here.

MDS Proteomics Inc. signs agreement with Eli Lilly Canada Inc. to use MDSP's PhosMap™ to determine the effect of Eli Lilly's kinase inhibitors on kinase targets. To read article click here.

Evotec OAI AG, KeyNeurotek AG and the Institute of Medical Technology Magdeburg GmbH (IMTM) sign small molecule drug discovery research agreement for CNS, autoimmune, allergic and dermatologic diseases. To read article click here.

-1/13/2003-

Press Release: In a new development Genevac Ltd. has radically enhanced obtainable sample drying performance from round bottom flasks and large tubes in the company's centrifugal evaporators through the use of novel Thermal Cushion technology. To read press release click here. Genevac Ltd. provides high-throughput centrifugal evaporation systems for combinatorial chemistry, high-throughput screening (HTS) and drug discovery. To read a review of Genevac's systems here at CombiChem Lab click here.

DuPont AG in Iowa to use Agilent's microarray and Rosetta informatics systems in their plant genomics. To read article click here. Agilent Technologies provides high-throughput HPLC analytical systems for combinatorial chemistry and drug discovery. For a review of Agilent's analytical systems here at CombiChem Lab click here.

FDA advisory panel gives thumbs up to Genzyme General Corp.'s drug Fabrazyme® for Fabry Disease.To read article click here.

New drug Rasagiline found effective against early-stage Parkinson's disease. To read article click here.

Centagenetix Inc. and Elixir Pharmaceuticals Inc. to merge. To read article click here.

Johnson & Johnson Pharmaceutical Research & Development. signs collaboration with Cetek Corporation to have access to Cetek's Capillary Electrophoresis screening technology. To read article click here.

Eos Biotechnology and Aventis Pasteur form 2-year collaboration for the identification of cancer vaccine targets. To read article click here.

BioFocus and Amgen Inc. form ion channel research collaboration. To read article click here.

-1/10/2003-

Press Release: Scynexis Europe Ltd has chosen advanced evaporation technology from Genevac Ltd. for a new "Hit Factory" being built just outside London, UK. To read press release click here. Genevac Ltd. provides high-throughput centrifugal evaporation systems for combinatorial chemistry, high-throughput screening (HTS) and drug discovery. To read a review of Genevac's systems here at CombiChem Lab click here.

Press Release: ESA Inc. has announced their presence at Pittcon 2003 in Orlando, USA (9th-14th March 2003) with the latest additions to range of highly sensitive and selective detectors for HPLC. To read press release click here.

IBC to host the "5th Annual Biological Safety & Production (BSP)" conference on June 9-11, 2003, in Reston, VA. For more information on this conference click here. IBC promotes and hosts a broad range of scientific oriented conferences. For more information on IBC here at CombiChem Lab click here.

IBC to host the "Plasma Protein Therapeutics Association (PPTA)" conference on June 11-13, 2003, in Reston, VA. For more information on this conference click here. IBC promotes and hosts a broad range of scientific oriented conferences. For more information on IBC here at CombiChem Lab click here.

Mera Pharmaceuticals Inc to acquire Ancile Pharmaceuticals Inc. To read article click here.

Deltagen Inc. sings Aventis Pharmaceuticals Inc. and Euroscreen s.a. to its DeltaOne™ program. To read article click here.

DNA LandMarks Inc. to acquire plant genotyping business from Paradigm Genetics Inc. To read article click here.

-1/09/2003-

Merck & Co. will try to buy Banyu Pharmaceutical Co. for about $1.52 billion. To read article click here.

Bioxel Pharma files US patent application for carbohydrate library derivatives of paclitaxel and docetaxel. To read article click here.

Genome Quebec sings agreement with Illumina Inc. to buy Illumina's BeadArray™ SNP genotyping platform. To read article click here.

Bayer AG buys exclusive rights from MorphoSys AG to develop HuCAL® antibody. To read article click here.

King Pharmaceuticals Inc. completes the acquisition of Meridian Medical Technologies. To read article click here.

FDA postpones review process of AstraZeneca's IRESSA® to May 2003. To read article click here.

Geron Corporation publishes study to further support the use of telomerase inhibitors for cancer treatment. To read article click here.

FDA gives approval to Alpha Therapeutic Corporation's Aralast™ alpha-1 proteinase inhibitor. To read article click here.

ZymoGenetics Inc. and Novo Nordisk A/S form collaboration for Interleukin 21 (IL-21) development. To read article click here.

CuraGen Corporation selects fully-human monoclonal antibody CR002 for kidney disease and sign's agreement with Abgenix Inc. to produce CR002. To read article click here.

deCODE genetics and Roche Diagnostics identify gene variations linked to increased osteoporosis risk. To read article click here.

Lynx Therapeutics Inc. and Takara Bio Inc. expand genomics collaboration. To read article click here.

-1/08/2003-

Signase Inc. and Tripos Inc. receive joint U.S. patent for protein tyrosine kinase (PTK) inhibitors . The patent is entitled "Thienopyrimidine-based inhibitors of the Src family." To read article click here. Tripos Inc. provides a suite of software tools for combinatorial chemistry and drug discovery. For a review of Tripos' software tools here at CombiChem Lab click here.

Dyax Corp. receives European approval for its recombinant inhibitor DX-88 for treatment of acquired and hereditary angioedema. To read article click here. Biotage Inc., a division of Dyax Corp., has a broad variety of purification systems for drug discovery. To find a review of Biotage's purification systems here at CombiChem Lab click here.

Applied Biosystems Group introduces its SNPlex™ system, a reagent and software product designed to allow researchers to conduct ultra high throughput genotyping. To read article click here. Applied Biosystems/MDS Sciex provides mass spectrometer systems for combinatorial chemistry and drug discovery. For a review of Applied Biosystems/MDS Sciex's systems here at CombiChem Lab click here.

Bristol-Myers Squibb Co. to stop commercializing its antidepressant drug Dutonin in Europe. To read article click here.

Meridian Medical Technologies Inc. shareholders approve aquisition by King Pharmaceuticals Inc. To read article click here.

FDA approves Aventis' antibiotic Ketek for the treatment of three types of respiratory infections. To read article click here.

Corixa Corporation to lincese antigen to Purdue Pharma L.P. To read article click here.

King Pharmaceuticals Inc.'s patent for its hypertension drug Altace challenged. To read article click here.

SRI International, Memorial Sloan-Kettering Cancer Center and Southern Research Institute license to Allos Therapeutics Inc. exclusive worldwide rights for anticancer drug PDX (10-propargyl-10-deazaaminopterin). To read article click here.

Roche and ICN Pharmaceuticals settle patent dispute over hepatitis C drug. To read article click here.

Amersham Biosciences and Geneva Bioinformatics form collaboration for the development and distribution of bioinformatics and training tools. To read article click here.

Chiron Corp. and GlaxoSmithKline form R&D and commercialization agreement for Chiron's small molecule drug targeting the Melanocortin 4 Receptor (MC-4R) pathway for obesity. To read article click here.

StemCells Inc. receives 3 U.S. patents, one of them for transplantation of human neural stem cells. To read article click here.

The Genomics Institute for the Novartis Research Foundation (GNF) licenses Rosetta Biosoftware's Rosetta Resolver system for gene expression research. To read article click here.

Evotec OAI AG and Oxagen Limited form collaboration for the identification of novel chemical compounds for one of Oxagen's targets. To read article click here.

Genelabs Technologies Inc. initiates Phase III clinical trial for Prestara™ (prasterone) for systemic lupus erythematosus treatment. To read article click here.

Johnson & Johnson Pharmaceutical Research & Development extendes agreement with Lexicon Genetics Incorporated for to continue having access to Lexicon's gene knockouts. To read article click here.

-1/07/2003-

The Center for Business Intelligence (CBI) announces additions to its Pharmaceutical Conference Series. To read article click here. CBI organizes and hosts a series of conferences in the pharmaceutical areas. For more information on CBI here at CombiChem Lab click here.

The Strategic Research Institute (SRI) will host the "Protein Kinases & Phosphatases in Drug Discovery & Development" conference on March 3-5, 2003, in San Diego, CA. To read article click here. SRI promotes and hosts a broad range of scientific oriented conferences. For more information on SRI here at CombiChem Lab click here.

The Strategic Research Institute (SRI) will host the "4th International Rx & Biotech Portfolio Management" conference on March 10-12, 2003, in La Jolla, CA. To read article click here. SRI promotes and hosts a broad range of scientific oriented conferences. For more information on SRI here at CombiChem Lab click here.

Applied Biosystems Group and the Immune Tolerance Network form gene expression research collaboration. To read article click here. Applied Biosystems/MDS Sciex provides mass spectrometer systems for combinatorial chemistry and drug discovery. For a review of Applied Biosystems/MDS Sciex's systems here at CombiChem Lab click here.

Genomic Solutions and Bruker Daltonics Inc. signi non-exclusive worldwide reseller agreement. To read article click here. Bruker Daltonics Inc. provides mass spectrometer systems for drug discovery applications. To read a review of Bruker Daltonics' Mass Spec systems here at CombiChem Lab click here.

Bristol-Myers Squibb Co. settles antitrust drugs litigations for $670 million. To read article click here.

Mylan Laboratories Inc. signs non-exclusive license agreement with Bristol-Myers Squibb Co. to manufacture and commercialize anxiety and cancer drugs. To read article click here.

Novartis AG appoints Theodor Sproll as its CEO for its Novartis Pharma Schweiz AG unit. To read article click here.

Boehringer Ingelheim International GmbH and Sagres Discovery form oncology research collaboration for the identification of novel drug targets. To read article click here.

GenVec Inc.'s drug for poor blood flow treatment in the legs fails clinical triasl. To read article click here.

Cephalon Inc. and MDS Proteomics Inc. sign 5-year research collaboration agreement. To read article click here.

Celgene Corp. provides update on clinical pipeline. To read article click here.

Sunesis Pharmaceuticals Inc. and Biogen Inc. form inflammatory and autoimmune drug research collaboration. To read article click here.

Morphotek Inc. and Abgenix Inc. form research alliance to develop high-titer cell lines. To read article click here.

XenoPort Inc. and ALZA Corporation form collaboration for prodrug research. To read article click here.

CuraGen Corp. and Pfizer Inc. form pharmacogenomics research collaboration to evaluate drug effectiveness. To read article click here.

Oxford GlycoSciences signs new proteomics services agreement with Pfizer Inc. To read article click here.

-1/06/2003-

Press Release: Tecan (UK) Ltd. has announced the further development of the highly successful Ultra microplate detection system by adding another detection technique - fluorescence lifetime. To read press release click here. Tecan provides the ChemSystem workstation and the TECAN MiniPrep systems for combinatorial chemistry and drug discovery. To read a review of TECAN's systems here at CombiChem Lab click here.

Press Release: The ProTeam Advanced Digest from Tecan (UK) Ltd. is a new next-generation solution for automated protein processing that may be easily integrated into the company's ProTeam Product Suite. To read press release click here. Tecan provides the ChemSystem workstation and the TECAN MiniPrep systems for combinatorial chemistry and drug discovery. To read a review of TECAN's systems here at CombiChem Lab click here.

Press Release: Autoscribe Ltd., in conjunction with exclusive US partner Zumatrix Inc., has announced their presence at Pittcon 2003 in Orlando, USA (9th-14th March 2003) with the latest additions to its portfolio of cutting edge LIMS products. To read press release click here.

The Strategic Research Institute (SRI) will host the "Cardiovascular Drug Discovery & Development Summit" conference on February 10-11, 2003, in San Diego, CA. To read article click here. SRI promotes and hosts a broad range of scientific oriented conferences. For more information on SRI here at CombiChem Lab click here.

FDA panel backs Merck & Co.'s drug Cozaar for preventing strokes. To read article click here.

Cellomics Inc. releases three new BioApplication software modules for the ArrayScan® High Content Screening Reader and the vHCS:Discovery ToolBox: Molecular Translocation, Micronucleus, and Cell Cycle. To read article click here.

MedImmune Inc. to licenseProtein Design Labs Inc.'s antibody humanization patent rights for up to three humanized antibodies. To read article click here.

Locus Discovery Inc. appoints H. Joseph Reiser as its new President and CEO. To read article click here.

Structural Bioinformatics Inc. and GeneFormatics Inc. to merge. To read article click here.

TriPath Oncology Inc. and AmeriPath Inc. sign agreement to commercialize a novel gene expression assay for malignant melanoma. To read article click here.

Scios Inc. releases an update on its p38 MAP kinase inhibitors SCIO-469 and SCIO-323. To read article click here.

Ligand Pharmaceuticals